POSC
Price
$1.62
Change
+$0.01 (+0.62%)
Updated
Nov 13 closing price
Capitalization
50.87M
Intraday BUY SELL Signals
RSCF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Capitalization
4.16M
Intraday BUY SELL Signals
Interact to see
Advertisement

POSC vs RSCF

Header iconPOSC vs RSCF Comparison
Open Charts POSC vs RSCFBanner chart's image
Positron
Price$1.62
Change+$0.01 (+0.62%)
Volume$11.9K
Capitalization50.87M
Reflect Scientific
Price$0.05
Change-$0.00 (-0.00%)
Volume$8K
Capitalization4.16M
POSC vs RSCF Comparison Chart in %
POSC
Daily Signal:
Gain/Loss:
RSCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
POSC vs. RSCF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POSC is a Hold and RSCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (POSC: $1.62 vs. RSCF: $0.05)
Brand notoriety: POSC and RSCF are both not notable
POSC represents the Medical/Nursing Services, while RSCF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: POSC: 185% vs. RSCF: 9%
Market capitalization -- POSC: $50.87M vs. RSCF: $4.16M
POSC [@Medical/Nursing Services] is valued at $50.87M. RSCF’s [@Pharmaceuticals: Other] market capitalization is $4.16M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $224.77B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.79B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POSC’s FA Score shows that 1 FA rating(s) are green whileRSCF’s FA Score has 1 green FA rating(s).

  • POSC’s FA Score: 1 green, 4 red.
  • RSCF’s FA Score: 1 green, 4 red.
According to our system of comparison, POSC is a better buy in the long-term than RSCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

POSC’s TA Score shows that 5 TA indicator(s) are bullish while RSCF’s TA Score has 4 bullish TA indicator(s).

  • POSC’s TA Score: 5 bullish, 4 bearish.
  • RSCF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, POSC is a better buy in the short-term than RSCF.

Price Growth

POSC (@Medical/Nursing Services) experienced а +14.89% price change this week, while RSCF (@Pharmaceuticals: Other) price change was +12.91% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.02%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +6.23%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.44%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was +7.03%.

Industries' Descriptions

@Medical/Nursing Services (+0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+1.44% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
POSC($50.9M) has a higher market cap than RSCF($4.16M). POSC YTD gains are higher at: 59.198 vs. RSCF (9.524).
POSCRSCFPOSC / RSCF
Capitalization50.9M4.16M1,224%
EBITDAN/A8.86K-
Gain YTD59.1989.524622%
P/E Ratio0.09N/A-
RevenueN/A1.72M-
Total CashN/A1.3M-
Total DebtN/A141K-
FUNDAMENTALS RATINGS
POSC vs RSCF: Fundamental Ratings
POSC
RSCF
OUTLOOK RATING
1..100
902
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
68
Overvalued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
5464
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

POSC's Valuation (25) in the null industry is somewhat better than the same rating for RSCF (68). This means that POSC’s stock grew somewhat faster than RSCF’s over the last 12 months.

POSC's Profit vs Risk Rating (48) in the null industry is somewhat better than the same rating for RSCF (100). This means that POSC’s stock grew somewhat faster than RSCF’s over the last 12 months.

RSCF's SMR Rating (91) in the null industry is in the same range as POSC (100). This means that RSCF’s stock grew similarly to POSC’s over the last 12 months.

POSC's Price Growth Rating (54) in the null industry is in the same range as RSCF (64). This means that POSC’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's P/E Growth Rating (3) in the null industry is significantly better than the same rating for POSC (100). This means that RSCF’s stock grew significantly faster than POSC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
POSCRSCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 24 days ago
70%
Bullish Trend 19 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 30 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
POSC
Daily Signal:
Gain/Loss:
RSCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENTO3.850.12
+3.22%
Entero Therapeutics Inc
CMBT9.640.05
+0.52%
CMB.TECH NV
LSBK14.35-0.04
-0.28%
Lake Shore Bancorp Inc
GFS34.17-0.64
-1.84%
GlobalFoundries
MYGN6.54-0.14
-2.10%
Myriad Genetics

POSC and

Correlation & Price change

A.I.dvisor tells us that POSC and SLDX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POSC and SLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POSC
1D Price
Change %
POSC100%
+4.02%
SLDX - POSC
27%
Poorly correlated
-0.66%
GMED - POSC
20%
Poorly correlated
-0.27%
RSMDF - POSC
9%
Poorly correlated
N/A
RSCF - POSC
8%
Poorly correlated
-4.17%
PFGTF - POSC
7%
Poorly correlated
N/A
More

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and VYCO have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and VYCO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
-4.17%
VYCO - RSCF
21%
Poorly correlated
N/A
POSC - RSCF
8%
Poorly correlated
+4.02%
SAFLF - RSCF
8%
Poorly correlated
N/A
RYLPF - RSCF
5%
Poorly correlated
N/A
RDGL - RSCF
-2%
Poorly correlated
-2.12%
More